Beryl Drugs Ltd.

View in App
34.79 -0.54 ▼-1.5%

19 April 2024, 04:01:00 PM
Volume: 432

Company Profile

View details >>
Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.beryldrugs.com
Market Cap 17.41 Cr.
Enterprise Value(EV) 21.93 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 2.33 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 14.76 Trailing Twelve Months Ending 2023-12
Industry PE 40.73 Trailing Twelve Months Ending 2023-12
Book Value / Share 18.34 Trailing Twelve Months Ending 2023-12
Price to Book Value 1.87 Calculated using Price: 34.33
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 0.51 Cr. 5,071,700 Shares
FaceValue 10
About Beryl Drugs Ltd.
Beryl Drugs incorporated in 1993 is into manufacturing and marketing of branded, generic pharmaceutical formulations. The company is one of leading manufacturer of I.V.fluids and small volume injectables.

Beryl Drugs Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Beryl Drugs Ltd. Performance

View details >>
1 Day
-1.53%
1 Week
+0.96%
1 Month
+14.10%
3 Month
+53.67%
6 Month
+47.42%
1 Year
+144.14%
2 Year
+244.46%
5 Year
+383.87%
10 Year
+9.57%

Beryl Drugs Ltd. Fundamental Ratios

View details >>
9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 1.31 2.54 1.74 14.8 8.35 0.63 3.09 -8.68 10
Return on Capital Employed (%) 4.92 5.55 4.48 16.88 9.96 4.05 6.28 -3.82 11.51
Return on Assets (%) 0.83 1.62 1.11 9.08 4.67 0.31 1.35 -3.63 4.36

Beryl Drugs Ltd. Balance Sheet

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 7 7 7 7 8 8 8 7 8 9
Non Curr. Liab. 0 0 0 0 1 3 3 2 3 3
Curr. Liab. 4 3 4 4 6 7 8 9 6 7
Minority Int.
Equity & Liab. 11 10 11 11 14 17 19 18 17 19
Non Curr. Assets 4 4 4 4 9 9 9 7 7 8
Curr. Assets 6 6 7 7 5 8 10 10 10 12
Misc. Exp. not W/O
Total Assets 11 10 11 11 14 17 19 18 17 19

Beryl Drugs Ltd. Profit and Loss

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 13 13 11 15 13 13 14 15 27 30
Other Income 0 0 0 1 0 0 0 0 0
Total Income 14 13 11 16 13 13 14 15 27 30
Total Expenditure -13 -13 -11 -14 -12 -12 -13 -14 -25 -27
PBIDT 1 1 1 2 1 1 2 1 2 3
Interest 0 0 0 0 0 0 0 0 0 0
Depreciation -1 0 0 0 0 -1 -1 -1 -1 -1
Taxation 0 0 0 0 0 0 0 0 0 0
Exceptional Items 0
PAT 0 0 0 1 1 0 0 -1 1 1
Adjusted EPS 0 0 0 2 1 0 0 -1 2 2

Beryl Drugs Ltd. Cash Flow

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 0 1 0 0 0 3 0 0 0 2
Cash Fr. Inv. 0 0 0 0 0 -5 -2 0 1 -1
Cash Fr. Finan. 0 0 0 0 0 2 2 -1 0 -1
Net Change 0 1 0 0 0 0 0 0 0 0
Cash & Cash Eqvt 0 1 1 1 0 0 0 0 0 0

Beryl Drugs Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%)
Promoter 24.92 24.92 24.92 24.92 24.92 26.38 26.38 26.38 26.38
Public 75.08 75.08 75.08 75.08 75.08 73.62 73.62 73.62 73.62
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
No. of Shareholders (in Lacs)

Beryl Drugs Ltd. Announcements

View details >>
Wed, 17 Apr 2024
COMPLIANCE CERTIFICATE FOR THE QUARTER ENDED 31.03.2024
COMPLIANCE CERTIFICATE
Sat, 13 Apr 2024
Compliances-Reg.24(A)-Annual Secretarial Compliance
NON APPLICABILITY CERTIFICATE
Sat, 13 Apr 2024
Declaration As Per Circular SEBI/HO/DDHS/CIR/P/2018/144 Dated 26.11.2018 Regarding Large Entity Or Large Corporate.
NON APPLICABILITY CERTIFICATE: BERYL DRUGS IS NOT IDENTIFIED AS LARGE ENTITY

Beryl Drugs Ltd. Technical Scans

View details >>
Fri, 19 Apr 2024
High Delivery Percentage High Delivery Percentage
Opening at High Opening at High
High Increase in 1 Month High Increase in 1 Month
High Increase in 3 Months High Increase in 3 Months
High Increase in 6 Months High Increase in 6 Months

Beryl Drugs Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 365,310.75 1,525.00 +0.5%
Cipla Ltd. 108,622.88 1,345.35 -0.2%
Dr. Reddy's Laboratories Ltd. 99,134.26 5,942.65 -0.3%
Divi's Laboratories Ltd. 97,408.39 3,673.85 -1.2%
Mankind Pharma Ltd. 93,565.44 2,362.00 -1.5%
Zydus Lifesciences Ltd. 92,794.90 925.95 -1.1%
Apollo Hospitals Enterprise Ltd. 88,715.85 6,152.25 +1.4%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 41.02 1,525.00 +0.5%
Cipla Ltd. Consolidated 2023-12 29.29 1,345.35 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 18.96 5,942.65 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-12 70.43 3,673.85 -1.2%
Mankind Pharma Ltd. Consolidated 2023-12 54.18 2,362.00 -1.5%
Zydus Lifesciences Ltd. Consolidated 2023-12 31.20 925.95 -1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 112.40 6,152.25 +1.4%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.85 1,525.00 +0.5%
Cipla Ltd. Consolidated 2023-12 4.19 1,345.35 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.69 5,942.65 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-12 7.47 3,673.85 -1.2%
Mankind Pharma Ltd. Consolidated 2023-12 10.53 2,362.00 -1.5%
Zydus Lifesciences Ltd. Consolidated 2023-12 4.92 925.95 -1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 13.14 6,152.25 +1.4%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,525.00 +0.5%
Cipla Ltd. Consolidated 2023-03 0.02 1,345.35 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,942.65 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,673.85 -1.2%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 2,362.00 -1.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 925.95 -1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,152.25 +1.4%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,525.00 +0.5%
Cipla Ltd. Consolidated 2023-03 12.85 1,345.35 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,942.65 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,673.85 -1.2%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,362.00 -1.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 925.95 -1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,152.25 +1.4%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,525.00 +0.5%
Cipla Ltd. Consolidated 2023-03 12.85 1,345.35 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,942.65 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,673.85 -1.2%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,362.00 -1.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 925.95 -1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,152.25 +1.4%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,525.00 +0.5%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,345.35 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,942.65 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,673.85 -1.2%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 2,362.00 -1.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 925.95 -1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,152.25 +1.4%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,525.00 +0.5%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,345.35 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,942.65 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,673.85 -1.2%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 2,362.00 -1.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 925.95 -1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,152.25 +1.4%

Beryl Drugs Ltd. FAQ's

What is Beryl Drugs share price?
Can I buy Beryl Drugs shares now?
What is the Market Cap of Beryl Drugs?
What are the key metrics to analyse Beryl Drugs?
What is the 52 Week High and Low of Beryl Drugs?
What is the trend of Beryl Drugs share price?